Topology and structure of the C1q-binding site on C-reactive protein

被引:134
作者
Agrawal, A
Shrive, AK
Greenhough, TJ
Volanakis, JE
机构
[1] Univ Alabama, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA
[2] Keele Univ, Sch Life Sci, Keele, Staffs, England
[3] Biomed Sci Res Ctr A Fleming, Vari, Greece
关键词
D O I
10.4049/jimmunol.166.6.3998
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The host defense functions of human C-reactive protein (CRP) depend to a great extent on its ability to activate the classical complement pathway. The aim of this study was to define the topology and structure of the CRP site that hinds C1q, the recognition protein of the classical pathway, We have previously reported that residue Asp(112) of CRP plays a major role in the formation of the C1q-binding site, while the neighboring Lys(114) hinders C1q binding, The three-dimensional structure of CRP Shows the presence of a deep, extended cleft in each protomer on the face of the pentamer opposite that containing the phosphocholine-binding sites. Asp(112) is part of this marked cleft that is deep at its origin but becomes wider and shallower close to the inner edge of the protomer and the central pore of the pentamer, The shallow end of the pocket is bounded by the 112-114 loop, residues 86-92 (the inner loop), the C terminus of the protomer, and the C terminus of the pentraxin alpha -helix 169-176, particularly Tyr(175) Mutational analysis of residues participating in the formation of this pocket demonstrates that Asp(112) and TSr175 are important contact residues for C1q binding, that GlU(88) influences the conformational change in C1q necessary for complement activation, and that Asn(158) and His(38) probably contribute to the correct geometry of the binding site, Thus, it appears that the pocket at the open end of the cleft is the C1q-binding site of CRP.
引用
收藏
页码:3998 / 4004
页数:7
相关论文
共 30 条
  • [1] AGRAWAL A, 1992, J BIOL CHEM, V267, P25352
  • [2] Agrawal A, 1997, J IMMUNOL, V158, P345
  • [3] AGRAWAL A, 1994, J IMMUNOL, V152, P5404
  • [4] The major receptor for C-reactive protein on leukocytes is Fcγ receptor II
    Bharadwaj, D
    Stein, MP
    Volzer, M
    Mold, C
    Du Clos, TW
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (04) : 585 - 590
  • [5] CHESEBRO B, 1972, BIOCHEMISTRY-US, V11, P766, DOI 10.1021/bi00755a014
  • [6] EVIDENCE FOR ARGININE RESIDUES IN THE IMMUNOGLOBULIN-BINDING SITES OF HUMAN-CLQ
    COMIS, A
    EASTERBROOKSMITH, SB
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 842 (01) : 45 - 51
  • [7] DUCLOS TW, 1989, J IMMUNOL, V143, P2553
  • [8] STRUCTURE OF PENTAMERIC HUMAN SERUM AMYLOID-P COMPONENT
    EMSLEY, J
    WHITE, HE
    OHARA, BP
    OLIVA, G
    SRINIVASAN, N
    TICKLE, IJ
    BLUNDELL, TL
    PEPYS, MB
    WOOD, SP
    [J]. NATURE, 1994, 367 (6461) : 338 - 345
  • [9] Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation
    Gabay, C
    Kushner, I
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) : 448 - 454
  • [10] Collectin structure:: A review
    Håkansson, K
    Reid, KBM
    [J]. PROTEIN SCIENCE, 2000, 9 (09) : 1607 - 1617